AEON Biopharma (AEON) Competitors $0.89 -0.07 (-7.70%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AEON vs. NNVC, TPST, CARA, CYTH, LSTA, MIRA, RLMD, NRSN, CASI, and CALCShould you be buying AEON Biopharma stock or one of its competitors? The main competitors of AEON Biopharma include NanoViricides (NNVC), Tempest Therapeutics (TPST), Cara Therapeutics (CARA), Cyclo Therapeutics (CYTH), Lisata Therapeutics (LSTA), MIRA Pharmaceuticals (MIRA), Relmada Therapeutics (RLMD), NeuroSense Therapeutics (NRSN), CASI Pharmaceuticals (CASI), and CalciMedica (CALC). These companies are all part of the "pharmaceutical products" industry. AEON Biopharma vs. Its Competitors NanoViricides Tempest Therapeutics Cara Therapeutics Cyclo Therapeutics Lisata Therapeutics MIRA Pharmaceuticals Relmada Therapeutics NeuroSense Therapeutics CASI Pharmaceuticals CalciMedica AEON Biopharma (NASDAQ:AEON) and NanoViricides (NYSE:NNVC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation. Is AEON or NNVC more profitable? AEON Biopharma's return on equity of 0.00% beat NanoViricides' return on equity.Company Net Margins Return on Equity Return on Assets AEON BiopharmaN/A N/A -994.63% NanoViricides N/A -87.90%-78.69% Does the media prefer AEON or NNVC? In the previous week, AEON Biopharma and AEON Biopharma both had 1 articles in the media. AEON Biopharma's average media sentiment score of -1.00 equaled NanoViricides'average media sentiment score. Company Overall Sentiment AEON Biopharma Negative NanoViricides Negative Which has more volatility & risk, AEON or NNVC? AEON Biopharma has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, NanoViricides has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Does the MarketBeat Community favor AEON or NNVC? AEON Biopharma received 8 more outperform votes than NanoViricides when rated by MarketBeat users. Likewise, 100.00% of users gave AEON Biopharma an outperform vote while only 0.00% of users gave NanoViricides an outperform vote. CompanyUnderperformOutperformAEON BiopharmaOutperform Votes8100.00% Underperform VotesNo VotesNanoViricidesOutperform VotesNo VotesUnderperform Votes57100.00% Do analysts rate AEON or NNVC? AEON Biopharma currently has a consensus price target of $360.00, suggesting a potential upside of 40,263.27%. Given AEON Biopharma's stronger consensus rating and higher possible upside, analysts plainly believe AEON Biopharma is more favorable than NanoViricides.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AEON Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NanoViricides 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals believe in AEON or NNVC? 22.8% of AEON Biopharma shares are held by institutional investors. Comparatively, 10.3% of NanoViricides shares are held by institutional investors. 0.9% of AEON Biopharma shares are held by company insiders. Comparatively, 4.6% of NanoViricides shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has better valuation & earnings, AEON or NNVC? NanoViricides is trading at a lower price-to-earnings ratio than AEON Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAEON BiopharmaN/AN/A-$36.63M$298.120.00NanoViricidesN/AN/A-$8.29M-$0.70-2.16 SummaryAEON Biopharma beats NanoViricides on 9 of the 13 factors compared between the two stocks. Get AEON Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AEON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AEON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEON vs. The Competition Export to ExcelMetricAEON BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.08M$6.92B$5.61B$8.62BDividend YieldN/A2.55%5.28%4.17%P/E Ratio4.968.6727.1419.96Price / SalesN/A262.53411.83157.63Price / CashN/A65.8538.2534.64Price / Book-0.226.597.064.69Net Income-$36.63M$143.75M$3.23B$248.14M7 Day Performance22.21%3.72%2.67%2.39%1 Month Performance81.28%11.01%8.82%6.05%1 Year Performance-99.18%3.87%31.44%13.60% AEON Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEONAEON Biopharma2.6954 of 5 stars$0.89-7.7%$360.00+40,263.3%-99.1%$10.08MN/A4.965Negative NewsShort Interest ↑Gap DownNNVCNanoViricides0.0852 of 5 stars$1.54+1.3%N/A-53.9%$24.75MN/A-2.1420Short Interest ↑TPSTTempest Therapeutics2.5491 of 5 stars$6.70+12.6%$30.00+347.8%-81.5%$24.67MN/A-4.3820News CoverageGap UpCARACara Therapeutics1.4911 of 5 starsN/A$36.00+∞N/A$24.33M$7.14M-0.2580Gap DownHigh Trading VolumeCYTHCyclo TherapeuticsN/A$0.72flat$0.95+31.8%N/A$23.72M$870.73K-0.809LSTALisata Therapeutics2.4746 of 5 stars$2.74+5.0%$15.00+447.4%-33.0%$23.61M$1M-1.0930News CoverageGap UpMIRAMIRA Pharmaceuticals3.3749 of 5 stars$1.39+3.0%$14.00+907.2%+61.3%$23.52MN/A-2.482Short Interest ↓RLMDRelmada Therapeutics4.8196 of 5 stars$0.71-5.5%$4.25+499.9%-74.8%$23.52MN/A-0.2510Positive NewsNRSNNeuroSense Therapeutics2.2266 of 5 stars$1.69+9.7%$14.00+728.4%+146.5%$23.10MN/A-2.6410CASICASI Pharmaceuticals4.3943 of 5 stars$1.87-1.3%$4.00+114.5%-44.7%$22.94M$31.37M-0.84180CALCCalciMedica2.7978 of 5 stars$1.64-4.1%$18.00+997.6%-65.4%$22.91MN/A-1.5230News Coverage Related Companies and Tools Related Companies NNVC Alternatives TPST Alternatives CARA Alternatives CYTH Alternatives LSTA Alternatives MIRA Alternatives RLMD Alternatives NRSN Alternatives CASI Alternatives CALC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AEON) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AEON Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
